This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Eli Lilly and Company. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: The Innovations of Mario Barberis
Introduction
Mario Barberis is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of KRas inhibitors. His work has the potential to impact cancer treatment and improve patient outcomes.
Latest Patents
Mario Barberis holds a patent for KRas inhibitors. The present invention provides compounds of the formula that are designed to inhibit the KRas protein, which is often mutated in various cancers. This innovation represents a crucial step forward in targeted cancer therapies.
Career Highlights
Mario Barberis is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role involves research and development, focusing on innovative solutions to complex medical challenges. His expertise in the field has been instrumental in advancing therapeutic options for patients.
Collaborations
Mario has collaborated with esteemed colleagues, including David Anthony Barda and Jolie Anne Bastian. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the research process.
Conclusion
Mario Barberis is a prominent figure in the field of pharmaceutical innovation, with a focus on KRas inhibitors. His contributions to cancer research and development at Eli Lilly and Company highlight the importance of collaboration and innovation in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile